m27,3'-OGP3G (ARCA Cap Analog) - Solution

For research use only.
Please centrifuge briefly before opening (volume ≤2 ml).
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.
Shelf Life: 12 months after date of delivery
Molecular Formula: C22H31N10O18P3 (free acid)
Molecular Weight: 816.46 g/mol (free acid)
Exact Mass: 816.10 g/mol (free acid)
CAS#: 400806-46-4 (acid), 400806-60-2 (Trisodium salt)
Purity: ≥ 98 % (HPLC)
Form: solution in water
Color: colorless to slightly yellow
Concentration: 100 mM - 110 mM
pH: 7.25 ±0.25
Spectroscopic Properties: λmax 255 nm, ε 22.6 L mmol-1 cm-1 (Tris-HCl pH 7.5)
Related products: HighYield T7 RNA Synthesis Kit, #RNT-101
Selected References:
Jemielity et al. (2003) Novel anti-reverse cap analogs with superior translational properties. RNA 9:1108.
Peng et al. (2002) Synthesis and application of a chain-terminating dinucleotide mRNA cap analog. Org. Lett. 4 (2):161.
Stepinski et al. (2001) Synthesis and properties of mRNAs containing the novel anti-reverse cap analogs 7-methyl (3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG. RNA 7:1486.
| Cat. No. | Amount | Price |
|---|---|---|
| NU-855S | 10 μl (100 mM) | 78,71 € |
| NU-855L | 5 x 10 μl (100 mM) | 354,24 € |
At this point, external content from bioz.com is embedded. When it loads, data (e.g. your IP address) is transmitted to the provider.
Scientific citations for Jena Bioscience nu-855
13 scientific citations and 0 citation images found by Bioz.
-
AI-Informed neoantigen prioritization enables a multi-epitope mRNA/LNP vaccine with antigen-specific immunogenicity and antitumor activity
bioRxiv, 2026-07-10 · DOI:10.64898/2026.07.06.736667
PrePrint: .. design and mRNA batch, either ARCA or CleanCap AG (3′-O-Me) cap analogs were used.. ARCA-capped mRNA was generated using
m27,3′-OGP3G ARCA Cap Analog solution (Jena Bioscience , ), whereas CleanCap-capped mRNA was generated using CleanCap Reagent AG (3′-O-Me) (TriLink, N-7413-100).. Following IVT, residual DNA template was removed by DNase I treatment using RNase-free DNase ..NU-855 L -
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families
Redox Biology, 2026-06-01 · PMID:41931906
.. used pseudouridine-5′-triphosphate (B7972, ApexBio) instead of UTP.We used pseudouridine-5′-triphosphate (B7972, ApexBio) instead of UTP.. We included the m 2
7,3'−O GP 3 G ARCA Cap Analog (NU-855 L,Jena Bioscience ) in the reaction in a final concentration of 6 mM.. We purified the in vitro transcribed RNA using the RNA Clean & Concentrator-25 kit .. -
Activation of the Rat P2X7 Receptor by Functionally Different ATP Activation Sites.
Cells, 2025-06-25 · PMID:40558482
.. to generate S3rP2X7- and S3rP2X7ko-containing concatamers in any desired order.. cRNA was synthesized as previously described in detail [24] including co-transcriptional incorporation of the anti-reverse cap analog (ARCA Cap Analog,
;m27,3 ′−OGp3G;NU-855 Jena Bioscience , Jena, Germany) to ensure the correct orientation at the ATG start codon of the cRNA [25].. Polyadenylation, which enhances cRNA translation in X. laevis oocytes [26], ..